Dr Timothy Low (Top Motivational Speaking Voice) ,PBM,Author,CEO,Board Director

Our mission is to revolutionize Last-Mile delivery in Smart Cities with our Autonomous Final-Mile Delivery PaaS.

Conducted thorough financial analysis of healthcare-related investments, evaluating risks and opportunities to guide decision-making processes. Utilized financial models, projections, and valuation methodologies to assess potential returns. I also researched and analyzed healthcare industry trends, regulatory changes, and market dynamics to identify investment prospects. Stayed informed about healthcare policies, reimbursement structures, and emerging technologies impacting the sector. I have also led due diligence processes for healthcare investment opportunities, assessing the viability of projects and potential impacts on financial performance. Assessed target companies, evaluating their financial health and competitive positioning. Prepared comprehensive investment reports, documenting key findings, analyses, and recommendations for internal and external stakeholders. Ensured accuracy and transparency in all reporting activities. Accomplishments • Participated and completed >30 Healthcare Deals, MOIC 3.2 X, IRR >20%, and invested USD 500 Million

Drawing from his decades of leadership experience as CEO for large organizations, Dr. Timothy dives into the reasons why some companies can achieve one success after another while others fall into obscurity. In the Triangulation of Success, he explained that it’s all about how the service of the leader impacts the organization, flowing from the top-level management to the staff member on the ground. A consistent theme throughout the book is the idea that people are the greatest asset to a company. As a leader in your career, the way you treat people means all the difference between imminent failure and great success.  As we face the predicament of geopolitical crises and the unprecedented threat of a global virus today, the need to be caring and empathetic to the needs of the people around us has never been greater.

AUM Biosciences (AUM) is an oncology-focused Asian biotechnology company committed to developing affordable cancer therapies. AUM is dedicated to revolutionizing the existing inefficient drug development paradigm by harnessing the power of precision medicine and digitalisation. AUM focuses on early stage development of innovative treatment of cancers prevalent in Asia with the potential to address global markets. Led by a highly experienced management team with over 100 years of combined oncology drug development experience, AUM is disrupting the drug development paradigm by implementing a holistic approach to developing drugs. Headquartered in Singapore, AUM is strategically positioned to work, partner and collaborate with leading research institutes, pharmaceutical companies and clinicians globally. AUM is the recipient of Frost & Sullivan’s 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class composition of matter technologies. 1) MNK Inhibition and 2) Multi-Kinase Inhibition (PIM/PI3K/mTOR).

The BayHelix Group is a non-profit professional organization of business leaders with a mission to shape the growth of the life sciences and healthcare industry. Founded in 2001 in the San Francisco Bay Area, BayHelix has grown to over 800 members globally with a strong presence in China and the US. BayHelix aspires to foster and create business opportunities, supply and nurture leaders for the community, and network and share information and experience among its members. The diverse membership base covers many of the world’s top pharmaceutical and biopharmaceutical companies, leading professional services and investment firms, as well as start-up biotech companies in China and the US. BayHelix membership is by-invitation only. Over two thirds of members are C-level executives. The majority of them are cross trained in science and business as well as bilingual in Chinese and English. BayHelix has become an influential organization that connects emerging biopharmaceutical companies in China to their counterparts around the world.

Health FX is revolutionising the Healthcare industry by combining the power of A.I./Machine Learning with Blockchain to optimise patient-specialist matching, enable seamless insurance pre-approvals/rebates and payments, and provide consumers and healthcare providers with validated reviews.

Author, Patching Up Wellness: Riding the Wave of Light A science-informed, narrative-driven exploration of phototherapy and regenerative wellness, Patching Up Wellness: Riding the Wave of Light bridges Western medicine, emerging biophotonic science, and holistic health. Written from the perspective of a medical doctor and former hospital CEO, the book demystifies photobiomodulation, wearable light technologies, and cellular signalling, translating complex science into practical, human-centred insights. Blending clinical evidence, case stories, and reflective storytelling, the book positions light-based, non-invasive therapies as adjunctive tools for prevention, recovery, longevity, and personalised wellness, while emphasising medical responsibility, integration with conventional care, and patient empowerment.

I am a healthcare executive with a proven track record in steering organizations toward operational excellence and sustainable growth. I am also dedicated to fostering innovation, optimizing patient outcomes, and driving financial performance. Aim to lead a visionary healthcare organization that prioritizes patient-centric care, embraces technological advancements, and achieves unparalleled success in a rapidly evolving healthcare landscape. I also spearhead strategic initiatives to align organizational goals with evolving healthcare trends. Visionary leadership in navigating complex healthcare landscapes for sustained growth. I have expertise in steering boards through governance challenges and ensuring regulatory compliance. Guiding organizations in adhering to healthcare policies, ethical standards, and legal frameworks.

Provide visionary leadership, setting the strategic direction for the hospital in alignment with industry trends and regulatory requirements. Drive organizational growth through the development and execution of comprehensive business strategies. I also oversee financial performance, ensuring sustainable revenue streams and cost-effective operations. Implement budgetary controls, optimize resource allocation, and monitor financial health to achieve profitability targets. My role also entails streamlining hospital operations for efficiency, implementing process improvements and quality assurance measures. Oversee the execution of policies and procedures to ensure compliance with healthcare regulations. Accomplishments: • Bagged the 50 Most Talented Healthcare Leaders of Asia Award at the Chief Marketing Officer (CMO) Asia Event in Aug 2016. • Authored Book titled “The Triangulation of Success” in Nov 2021

Pavilion Capital is wholly owned and funded by Temasek(Singapore State Investment) , an investment company based in Singapore. Our focus is on funds and direct co-investments in companies that ride on the growth and transformation of the North Asia and Southeast Asia economies. We also invest in US, Europe and Isreal. We pursue investments across different sectors, particularly in innovative technology and healthcare. We embrace sustainability and apply ESG considerations in our investment activities. As at Dec 2020, Pavilion’s total AUM is over S$14b across > 100 GP relationships; > 200 funds. Participated and completed >30 Healthcare Deals , MOIC 3.2 X , IRR >20% , invested USD 500 Mil.

Farrer Park Hospital is a new private tertiary healthcare institute establishment. Designed by healthcare practitioners, the hospital aims to deliver a patient-centric healthcare experience in Singapore and Asia. The hospital is part of Connexion – Asia’s first integrated lifestyle hub for healthcare and wellness that also houses a specialist medical centre and a five-star hotel and spa. Farrer Park Hospital is part of Singapore-based The Farrer Park Company, formed by a group of eminent private medical and hospitality specialists with selected foreign investors. The hospital’s care philosophy extends beyond healing and the management of disease, to engaging patients as partners in the pursuit of good health. Patients are treated by an experienced team of medical and health specialists in an environment meticulously designed to maximise comfort and efficiency while promoting well-being, rest and recovery. The hospital’s services and facilities include operation suites, a diagnostic imaging centre, a radiotherapy suite, nuclear medicine suite and laboratory. Patients are accommodated in four floors of inpatient suites with a range of room sizes and privacy levels to match patient’s preferences and comfort levels. Dr Timothy Low has been awarded the “50 Most Talented Healthcare Leaders of Asia” award at the Chief Marketing Officer (CMO) Asia event held at Pan Pacific Hotel on 5 August 2016.